Syntacoll

Specialises in manufacturing collagen-based absorbable surgical implants in a 4,800m2, GMP compliant, state-of-the-art collagen facility with a class 1 licence for collagen-based drugs. This acquisition strengthens the Group’s existing collagen business.

Peters Surgical

Is a leading European provider of specialty surgical products. Following completion of our recent acquisition of Peters Surgical, AMS believe this deal will further strengthen the Group’s position as a leading, global Medical Device manufacturer.